NCT04543136View on ClinicalTrials.gov

Investigation of Non-CE Marked Intermittent Catheters.

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 3, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Retention, Urinary
Interventions
DEVICE

SpeediCath® Standard male

Intermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard male.

DEVICE

New intermittent Variant 1 catheter for males

Intermittent catheterization through the urethra draining the bladder, using the new Variant 1 catheter.

DEVICE

New intermittent Variant 2 catheter for males

Intermittent catheterization through the urethra draining the bladder, using the new Variant 2 catheter.

Trial Locations (1)

Unknown

Blegdamsvej 9, Urologisk klinik Afsnit 2112, Rigshospitalet, Copenhagen

Sponsors

Lead Sponsor

Coloplast A/S
All Listed Sponsors
lead

Coloplast A/S

INDUSTRY